Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 922-929 |
Journal | Annals of the Rheumatic Diseases |
Volume | 68 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2009 |
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
D. van der Heijde, M.H. Schiff, J. Sieper, A.J. Kivitz, R.L. Wong, H. Kupper, B.A.C. Dijkmans, P.J. Mease, J.C. Davis
Research output: Contribution to journal › Article › Academic › peer-review